References
Alizadeh Z, Mazinani M, Shakerian L, Nabavi M, Fazlollahi MR. DOCK2 deficiency in a patient with hyper IgM phenotype. J Clin Immunol. 2018;38:10–2.
Alosaimi MF, Shendi H, Beano A, Stafstrom K, El Hawary R, Meshaal S, et al. T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients. J Allergy Clin Immunol. 2019;144(306–9):e2.
Moens L, Gouwy M, Bosch B, Pastukhov O, Nieto-Patlan A, Siler U, et al. Human DOCK2 deficiency: report of a novel mutation and evidence for neutrophil dysfunction. J Clin Immunol. 2019;39:298–308.
Dobbs K, Dominguez Conde C, Zhang SY, Parolini S, Audry M, Chou J, et al. Inherited DOCK2 deficiency in patients with early-onset invasive infections. N Engl J Med. 2015;372:2409–22.
Guo X, Shi N, Cui XB, Wang JN, Fukui Y, Chen SY. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling. Circ Res. 2015;116:e71-80.
Funding
This research was in part funded by the IRCM Foundation and the J -Louis Lévesque Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All authors reviewed and agreed with the final manuscript.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
D’Astous-Gauthier, K., Desjardins, A., Marois, L. et al. DOCK2 Deficiency Diagnosed 18 Years After Hematopoietic Stem Cell Transplantation. J Clin Immunol 41, 1400–1402 (2021). https://doi.org/10.1007/s10875-021-01040-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-021-01040-4